AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
1-Year Return
18.84%
This Quarter Return
+8.91%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
-$27.2M
(-15%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-23.3%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
297
New
63
Increased
40
Reduced
80
Closed
81
Top Buys
| 1 |
ABVX
Abivax
ABVX
|
$2.86M |
| 2 |
Pfizer
PFE
|
$2.3M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
$2.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$1.93M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$3.38M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.95M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$2.78M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.74M |
| 5 |
TSVT
2seventy bio
TSVT
|
$2.58M |
Sector Composition
| 1 | Healthcare | 59.47% |
| 2 | Real Estate | 11.94% |
| 3 | Financials | 4.93% |
| 4 | Industrials | 2.46% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
NVIDIA
NVDA
$4.07T
| $38.1K | 0.03% |
+770
| New | +$38.1K |
|
202
Zscaler
ZS
$42.7B
| $37.7K | 0.03% |
+170
| New | +$37.7K |
|
203
Datadog
DDOG
$47.5B
| $37.4K | 0.03% |
+308
| New | +$37.4K |
|
204
DoorDash
DASH
$105B
| $36.7K | 0.02% |
+371
| New | +$36.7K |
|
205
Fortinet
FTNT
$60.4B
| $34.1K | 0.02% |
583
-58
| -9% | -$3.4K |
|
206
Sarepta Therapeutics
SRPT
$1.96B
| $29.4K | 0.02% |
305
-31
| -9% | -$2.99K |
|
207
Confluent
CFLT
$6.67B
| $26.6K | 0.02% |
1,135
-114
| -9% | -$2.67K |
|
|
SWAV
208
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $25.9K | 0.02% |
136
-13
| -9% | -$2.48K |
|
209
Ventyx Biosciences
VTYX
$180M
| $24.7K | 0.02% |
10,000
-2,000
| -17% | -$4.94K |
|
210
iShares MSCI Chile ETF
ECH
$726M
| $18.7K | 0.01% |
+662
| New | +$18.7K |
|
211
Phinia Inc
PHIN
$2.28B
| $12.1K | 0.01% |
399
-49
| -11% | -$1.48K |
|
|
TSVT
212
DELISTED
2seventy bio
TSVT
| – | – |
-657,500
| Closed | -$2.58M |
|
213
ADC Therapeutics
ADCT
$398M
| – | – |
-1,068,468
| Closed | -$958K |
|
214
Archer Daniels Midland
ADM
$30.2B
| – | – |
-1,290
| Closed | -$97.3K |
|
215
Aflac
AFL
$57.2B
| – | – |
-3,520
| Closed | -$270K |
|
216
American International
AIG
$43.9B
| – | – |
-1,902
| Closed | -$115K |
|
217
Akero Therapeutics
AKRO
$3.58B
| – | – |
-8,000
| Closed | -$405K |
|
218
Albemarle
ALB
$9.6B
| – | – |
-165
| Closed | -$28.1K |
|
219
Alkermes
ALKS
$4.94B
| – | – |
-42,500
| Closed | -$1.19M |
|
220
Allient
ALNT
$772M
| – | – |
-30,000
| Closed | -$928K |
|
221
Amgen
AMGN
$153B
| – | – |
-890
| Closed | -$239K |
|
222
Arista Networks
ANET
$180B
| – | – |
-1,104
| Closed | -$50.8K |
|
223
APA Corp
APA
$8.14B
| – | – |
-4,632
| Closed | -$190K |
|
224
Antero Resources
AR
$10.1B
| – | – |
-2,737
| Closed | -$69.5K |
|
225
Accuray
ARAY
$170M
| – | – |
-350,000
| Closed | -$952K |
|